Concern, confusion over COX-2s leads to reduction in use

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1479, 2005-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COX-2 use grows despite little added benefit over NSAIDs

Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

COX-2 use grows despite little added benefit over NSAIDs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

COX-2 use grows despite little added benefit over NSAIDs

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

COX-2s preferred over nonselective NSAIDs in coumarin recipients

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

COX-2 use according to NICE guidance suboptimal

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 486, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite